Approved indications: Omnaris is indicated for the treatment of nasal symptoms (such as congestion, runny nose, sneezing, and itching) of seasonal allergic rhinitis in adults and children 6 years and older, and perennial (year-round) allergic rhinitis in adults and adolescents 12 years and older.

Off-label uses: Some clinicians may use intranasal ciclesonide for related nasal inflammatory conditions (for example, nonallergic rhinitis or chronic rhinosinusitis), but these uses are not FDA-approved and supporting evidence is more limited than for better-studied intranasal steroids like fluticasone or mometasone.

Efficacy expectations: Many people begin to notice some symptom relief within a few days; maximal benefit for seasonal allergies often occurs after about 1 to 2 weeks of daily use, and improvement in perennial symptoms may continue to increase over several weeks. In head-to-head and comparative data, Omnaris provides symptom control broadly similar to other modern intranasal corticosteroids when used consistently once daily.

Typical dosing (intranasal only): For seasonal allergic rhinitis, adults and children 6 years and older use 2 sprays in each nostril once daily (total daily dose 200 mcg). For perennial allergic rhinitis, adults and adolescents 12 years and older use 2 sprays in each nostril once daily (200 mcg). Do not exceed a total of 2 sprays in each nostril (200 mcg) per day.

How to use: Gently shake the bottle before each use. Before first use, prime the pump by spraying into the air 8 times away from the face; if not used for 4 consecutive days, gently shake and reprime with 1 spray (or until a fine mist appears). Keep your head upright, insert the tip into one nostril, aim slightly outward (away from the septum), close the other nostril, breathe in gently through the nose while spraying, and repeat for the other nostril; avoid blowing your nose for a few minutes afterward. It can be used with or without food and is usually taken once daily at about the same time.

Special dosing instructions: Use the lowest effective dose and do not increase the number of sprays without medical advice. Avoid spraying directly onto the nasal septum to reduce risk of irritation or perforation, and do not use in the eyes or mouth.

Missed dose: If you miss a dose, use it as soon as you remember that day; if it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not use extra sprays to make up for a missed dose.

Overdose: An accidental single extra dose is unlikely to cause serious harm, but repeated overuse can increase the chance of systemic steroid side effects (such as adrenal suppression or effects on growth). In case of significant overuse or if someone swallows a large amount or has worrisome symptoms, contact a healthcare provider, poison control center, or emergency services.

Common side effects: The most frequently reported effects include headache, nosebleeds, nasal irritation or burning, sore throat, cough, and upper respiratory infections; these are usually mild to moderate and tend to appear in the first days to weeks of treatment, often improving with continued use.

Serious or rare adverse effects: Seek prompt medical attention for frequent or heavy nosebleeds, persistent sores or crusts inside the nose, signs of a nasal or throat fungal infection (such as white patches or persistent soreness), severe facial pain, vision changes (blurred vision, eye pain, seeing halos), symptoms of adrenal problems (extreme fatigue, weakness, dizziness, nausea), severe allergic reaction (rash, swelling, trouble breathing), or if a child’s growth seems to slow.

Warnings and precautions: Use Omnaris with caution if you have recent nasal surgery, trauma, or ulcers, active or untreated infections (especially tuberculosis, fungal, or viral infections, or ocular herpes), or a history of glaucoma or cataracts. Long-term use of intranasal steroids may slightly reduce growth velocity in children, so periodic monitoring of height is recommended; patients with visual symptoms or long-term use may need periodic eye exams. There are no specific dose adjustments for kidney or liver disease, but in severe liver impairment or when combined with other steroids, clinicians may monitor more closely for systemic steroid effects.

Pregnancy and breastfeeding: Human data are limited, but because Omnaris is used in the nose and has low systemic absorption at recommended doses, many clinicians consider it an option in pregnancy or breastfeeding when the expected benefit justifies potential risk; decisions are individualized and should be made with a healthcare professional.

Overall safety profile: Compared with other intranasal corticosteroids, Omnaris has a similar safety profile, with low overall rates of systemic steroid effects when used at recommended doses and good local tolerability for most patients.

Reporting side effects and safety updates: Side effects can be reported to the FDA’s MedWatch program (by phone at 1-800-FDA-1088 or through the MedWatch website) or to the manufacturer, and patients can check FDA drug safety communications online for any new warnings about ciclesonide or Omnaris.

Drug and supplement interactions: Because Omnaris has low systemic absorption at recommended doses, clinically significant interactions are uncommon, but strong inhibitors of the enzyme CYP3A4 (such as certain antifungals like ketoconazole and some HIV or hepatitis C medicines) can increase blood levels of corticosteroids and may theoretically raise the risk of systemic side effects, especially if you are also using other steroid medicines. Using multiple corticosteroid products (e.g., oral or inhaled steroids) together may have additive effects on adrenal function, bone, and growth.

Food, alcohol, and procedures: Food and typical alcohol intake do not meaningfully affect Omnaris because it is used in the nose rather than taken by mouth, and it does not have known interactions with common imaging contrast agents or most diagnostic procedures.

Precautions and conditions requiring caution: Tell your clinician if you have or have had nasal ulcers, recent nasal surgery or trauma, chronic or recurrent infections (tuberculosis, fungal infections, chronic or untreated bacterial or viral infections, or ocular herpes), glaucoma, cataracts, osteoporosis, or immune system problems. Avoid use in the nose until it has healed after surgery or significant injury. Extra care is needed in children because long-term intranasal steroid use can slightly slow growth, and in people exposed to chickenpox or measles who have not had these illnesses or been vaccinated, as corticosteroids may worsen these infections.

Monitoring needs: During long-term treatment, clinicians may periodically examine the inside of the nose for irritation, bleeding, or infection; monitor height and growth in children; and consider eye examinations if visual symptoms occur or if Omnaris is used for extended periods, especially in patients with glaucoma or cataract risk. In patients receiving high cumulative steroid exposure (from multiple steroid medicines or high doses), clinicians may occasionally assess adrenal function if symptoms suggest suppression.

Q: What does Omnaris treat?
A: Omnaris is a prescription nasal spray used to treat nasal symptoms such as congestion, runny nose, sneezing, and itching caused by seasonal allergies in adults and children 6 years and older, and by year-round (perennial) allergies in adults and adolescents 12 years and older.

Q: How long does Omnaris take to start working?
A: Some people notice improvement within a few days, but it may take about 1 to 2 weeks of daily use to feel the full benefit for seasonal allergies and several weeks for year-round symptoms.

Q: Can I use Omnaris every day long term?
A: Omnaris is designed for once-daily, ongoing use during allergy seasons or for persistent allergies, and many people use it for extended periods under medical supervision, with clinicians monitoring for nasal irritation, eye problems, or growth effects in children.

Q: Can I use Omnaris with oral antihistamines or decongestants?
A: Yes, Omnaris is often combined with oral antihistamines or other allergy medicines when needed, but you should tell your healthcare provider all the medicines you take so they can avoid unnecessary duplication or excessive steroid exposure.

Q: Is Omnaris safe for children?
A: Omnaris is approved for seasonal allergic rhinitis in children 6 years and older and for perennial allergic rhinitis in adolescents 12 years and older; it is generally well tolerated, but because long-term steroid use may slightly slow growth, children using it regularly should have their growth checked periodically.

Q: What should I do if my nose still feels blocked while using Omnaris?
A: Make sure you are using the spray correctly every day, allow at least 1 to 2 weeks for full effect, and if congestion remains troublesome, consult your healthcare provider, who may adjust your treatment, check for other causes (such as infection or nasal polyps), or add other therapies.

Storage: Store Omnaris upright at room temperature (about 59°F to 86°F), protect it from heat and freezing, keep it in the foil pouch until first use, and keep it out of the reach of children.

In-use limits: After priming, discard the bottle after you have used 120 sprays or 4 months after removing it from the foil pouch, even if some liquid remains, because the dose per spray may no longer be accurate.

Disposal: Place the empty or expired bottle in household trash unless your pharmacist or local waste authority recommends a medicine take-back program, and do not puncture, burn, or attempt to reuse the container.